Profile of Hepatitis B Virus, Hepatitis C Virus, Hepatitis D Virus and Human Immunodeficiency Virus Infections in Hemodialysis Patients of a Tertiary Care Hospital in Uttarakhand

Journal of Clinical and Experimental Hepatology

Volumn 3, Issue 1, 2013, Pages 24-28

  Mittal, Garima ^a   Gupta, Pratima ^a   Thakuria, Bhaskar ^b   Mukhiya, Gulshan K ^c   Mittal, Manish ^a  

^a HIMALAYAN INSTITUTE OF MEDICAL SCIENCES   (India)

^b Shubharti Medical College   (India)

^c Apollo Hospital   (Bangladesh)

Author keywords

ESRD; HBsAg; HBV; HCV; HD; HDV; Hemodialysis; Hepatitis B; Hepatitis C; Hepatitis D; HIV

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS D ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DELTA AGENT HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SEROCONVERSION; TERTIARY HEALTH CARE; TREATMENT DURATION;

EID: 84875804246     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2013.02.003     Document Type: Article

References (30)

1. Saha D., Agarwal S.K. Hepatitis and HIV infection during haemodialysis. J Ind Med Assoc 2001, 99:194-199.
2. Pujol F.H., Ponce J.G., Lema M.G., et al. High incidence of hepatitis C virus infection in HD patients in units with high prevalence. J Clin Microbiol 1996, 34:1633-1636.
3. Chawla N.S., Sajiv C.T., Pawar G., Pawar G. Hepatitis B and C virus infections associated with renal replacement therapy in patients with end stage renal disease in a tertiary care hospital in India - prevalence, risk factors and outcome. Indian J Nephrol 2005, 15:205-213.
4. Thyagrajan S.P., Jayaram S., Mohanavalli B. Prevalence of hepatitis B in the general population of India. Hepatitis B in India, Problems and Prevention 1996, 5-16. CBS Publishers and Distributers, New Delhi. 1sted. S.K. Sarin, A.K. Singal (Eds.).
5. Panda S.K., Panigrahi A.K. Biology of hepatitis C virus. Transfusion Associated Hepatitis, Diagnosis, Treatment and Prevention 1998, 57-66. CBS Publishers and Distributers, New Delhi. 1st ed. S.K. Sarin, G. Hess (Eds.).
6. Oesterreicher C., Hammer J., Koch U., et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995, 48:67-71.
7. Fabrizi F., Poordad F., Martin P., Hepatitis C. Infection and the patients with end-stage renal disease. Hepatology 2002, 36(1):3-10.
8. Delarocque-Astagneau E., Baffoy N., Thiers V., et al. Outbreak of hepatitis C virus infection in an haemodialysis unit: potential transmission by haemodialysis machine. Infect Control Hosp Epidemiol 2002, 23(6):328-334.
9. Reddy G.A., Dakshinamurthy K.V., Neelaprasad P., Gangadhar T., Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Ind J Med Microbiol 2005, 23(1):41-43.
10. Meyers C.M., Seeff L.B., Stehman-Breen C.O., Hoofnagle J.H. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003, 42(4):631-657.
11. Fabrizi F., de Vecchi A.F., Como G., Lunghi G., Martin P. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther 2005, 21(7):861-869.
12. Gupta P., Talekar M., Pathak V.P., Prasad R. Seroprevalence of hepatitis C and hepatitis B in Uttaranchal - a preliminary report. Indian Med Gaz 2002, CXXXVI(12):461-463.
13. Yilmaz M.E., Kara I.H., Sari Y., Duzen S., Usul Y., Isikoglu B. Seroprevalence and risk factors of HCV in dialysis patients in a university haemo-dialysis center of southeast Anatolia, Turkey. Dial Transplant 2001, 30:748-755.
14. Tokars J.I., Frank M., Alter M.J., Arduino M.J. National surveillance of dialysis-associated diseases in the United States 2000. Semin Dial 2002, 15:162-171.
15. Jadoul M., Poignet J.L., Geddes C. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004, 19(4):904-909.
16. Mendez Chacon P., Vidalon A., Vildosola H. Risk factors for hepatitis C in hemodialysis and its impact on the waiting list for kidney transplantation. Rev Gastroenterol Peru 2005, 25(1):12-18.
17. Ashis M. Hepatitis C in India. J Biosci 2008, 33(4):465-473.
18. Jaiswal S.K., Chitnis D.S., Salgia P., Sepaha A., Pandit C.S. Prevalence of hepatitis viruses among chronic renal failure patients on haemodialysis in Central India. Dial Transplant 2002, 31:234-240.
19. Chandra M., Khaja M.N., Hussain M.M., et al. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 2004, 47:374-376.
20. Jain P., Nijhawan S. Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance haemodialysis patients. World J Gastroenterol 2008, 14(4):2288-2289.
21. Jasuja S., Gupta A.K., Choudhry R., et al. Prevalence and associations of hepatitis C viremia in haemodialysis patients at a tertiary care hospital. Indian J Nephrol 2009, 19(2):62-67.
22. CendorogloNeto M., Draibe S.A., Silva A.E.B., et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995, 10:240-246.
23. Souza K.P., Luz J.A., Teles S.A., et al. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Mem Inst Oswaldo Cruz 2003, 98:599-603.
24. Hung K.Y., Chen W.Y., Yang C.S., Lee S.H., Wu D.J. Hepatitis B and Hepatitis C in haemodialysis patients. Dial Transplant 1995, 24(3):135-139.
25. Pol S., Dubois F., Mattlinger B., et al. Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in France. Transplantation 1992, 54:1096-1097.
26. Fissell R.B., Brag-Gresham J.L., Woods J.D., et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004, 65:2335-2342.
27. Jadoul M., Cornu C., Van Yperselle De Strihou C. Universal precautions prevent hepatitis C virus transmission: 54 month follow up of the Belgian multicenter study. Kidney Int 1998, 53:1022-1025. The Universities Clinques St Luc (UCL) collaborative Group.
28. Nemati E., Alavian S.M., Taheri S., Moradi M., Pourfarziani V., Einollahi B. Hepatitis C virus infection among patients on haemodialysis: a report from a single center in Iran. Saudi J Kidney Dis Transplant 2009, 20(1):147-153.
29. Alfurayh O., Sabeel A., Al Ahdal M.N., et al. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol 2000, 20(2):103-106. [S].
30. National Kidney Foundation KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 2006, 48(suppl 1):S1-S322.